APA
SPHS

American Portfolios Advisors’s Sophiris Bio, Inc. SPHS Stock Holding History

American Portfolios Advisors’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,000
Closed -$990 – 2821
2019
Q1 		$990 Sell
1,000
-300
-23% -$322 ﹤0.01% 2483
2018
Q4 		$1.08K Hold
1,300
– – ﹤0.01% 2248
2018
Q3 		$3.63K Buy
+1,300
New +$3.7K ﹤0.01% 2099

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BO
BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

American Portfolios Advisors's SPHS Position: Q2 2019 in Review

American Portfolios Advisors sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 1,000 shares — an estimated $990 sold.

American Portfolios Advisors first reported a position in SPHS in Q3 2018 and held it in 3 quarters. The position peaked at $3.63K in Q3 2018. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.

  • American Portfolios Advisors reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 1,000 Sophiris Bio, Inc. shares in Q2 2019, an estimated $990.
  • American Portfolios Advisors first reported a position in Sophiris Bio, Inc. in Q3 2018 and held it in 3 quarters.
  • American Portfolios Advisors's Sophiris Bio, Inc. position peaked at $3.63K in Q3 2018.
  • 22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.

Based on American Portfolios Advisors's 13F filing for Q2 2019, filed 24 Mar 2023.